These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32380185)

  • 1. Nicotinamide mononucleotide administration after sever hypoglycemia improves neuronal survival and cognitive function in rats.
    Wang X; Hu X; Zhang L; Xu X; Sakurai T
    Brain Res Bull; 2020 Jul; 160():98-106. PubMed ID: 32380185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
    Wang X; Hu X; Yang Y; Takata T; Sakurai T
    Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons.
    Chandrasekaran K; Choi J; Arvas MI; Salimian M; Singh S; Xu S; Gullapalli RP; Kristian T; Russell JW
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment.
    Suh SW; Aoyama K; Matsumori Y; Liu J; Swanson RA
    Diabetes; 2005 May; 54(5):1452-8. PubMed ID: 15855333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia.
    Suh SW; Aoyama K; Chen Y; Garnier P; Matsumori Y; Gum E; Liu J; Swanson RA
    J Neurosci; 2003 Nov; 23(33):10681-90. PubMed ID: 14627653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.
    Park JH; Long A; Owens K; Kristian T
    Neurobiol Dis; 2016 Nov; 95():102-10. PubMed ID: 27425894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice.
    Li HR; Liu Q; Zhu CL; Sun XY; Sun CY; Yu CM; Li P; Deng XM; Wang JF
    Redox Biol; 2023 Jul; 63():102745. PubMed ID: 37201414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide mononucleotide pretreatment improves long-term isoflurane anesthesia-induced cognitive impairment in mice.
    Xu J; Chen X; Liu S; Wei Z; Xu M; Jiang L; Han X; Peng L; Gu X; Xia T
    Behav Brain Res; 2024 Feb; 458():114738. PubMed ID: 37931707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice.
    Tarantini S; Valcarcel-Ares MN; Toth P; Yabluchanskiy A; Tucsek Z; Kiss T; Hertelendy P; Kinter M; Ballabh P; Süle Z; Farkas E; Baur JA; Sinclair DA; Csiszar A; Ungvari Z
    Redox Biol; 2019 Jun; 24():101192. PubMed ID: 31015147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAD
    Klimova N; Fearnow A; Long A; Kristian T
    Exp Neurol; 2020 Mar; 325():113144. PubMed ID: 31837320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease.
    Wang X; Hu X; Yang Y; Takata T; Sakurai T
    Exp Neurol; 2015 Sep; 271():145-54. PubMed ID: 26057947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms.
    Zhang XQ; Lu JT; Jiang WX; Lu YB; Wu M; Wei EQ; Zhang WP; Tang C
    Neuroscience; 2015 Apr; 291():230-40. PubMed ID: 25684751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo.
    Formentini L; Moroni F; Chiarugi A
    Biochem Pharmacol; 2009 May; 77(10):1612-20. PubMed ID: 19426698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of nicotinamide mononucleotide and lycopene prevents cognitive impairment and attenuates oxidative damage in D-galactose induced aging models via Keap1-Nrf2 signaling.
    Liu X; Dilxat T; Shi Q; Qiu T; Lin J
    Gene; 2022 May; 822():146348. PubMed ID: 35183682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise-induced benefits on glucose handling in a model of diet-induced obesity are reduced by concurrent nicotinamide mononucleotide.
    Yu J; Laybutt DR; Kim LJ; Quek LE; Wu LE; Morris MJ; Youngson NA
    Am J Physiol Endocrinol Metab; 2021 Jul; 321(1):E176-E189. PubMed ID: 34121447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to fluoride exacerbates the cognitive deficit of diabetic patients living in areas with endemic fluorosis, as well as of rats with type 2 diabetes induced by streptozotocin via a mechanism that may involve excessive activation of the poly(ADP ribose) polymerase-1/P53 pathway.
    Xiang J; Qi XL; Cao K; Ran LY; Zeng XX; Xiao X; Liao W; He WW; Hong W; He Y; Guan ZZ
    Sci Total Environ; 2024 Feb; 912():169512. PubMed ID: 38145685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide Mononucleotide Prevents Retinal Dysfunction in a Mouse Model of Retinal Ischemia/Reperfusion Injury.
    Lee D; Tomita Y; Miwa Y; Shinojima A; Ban N; Yamaguchi S; Nishioka K; Negishi K; Yoshino J; Kurihara T
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.
    Mills KF; Yoshida S; Stein LR; Grozio A; Kubota S; Sasaki Y; Redpath P; Migaud ME; Apte RS; Uchida K; Yoshino J; Imai SI
    Cell Metab; 2016 Dec; 24(6):795-806. PubMed ID: 28068222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety evaluation after acute and sub-chronic oral administration of high purity nicotinamide mononucleotide (NMN-C®) in Sprague-Dawley rats.
    Cros C; Cannelle H; Laganier L; Grozio A; Canault M
    Food Chem Toxicol; 2021 Apr; 150():112060. PubMed ID: 33587977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide pre-treatment ameliorates NAD(H) hyperoxidation and improves neuronal function after severe hypoxia.
    Shetty PK; Galeffi F; Turner DA
    Neurobiol Dis; 2014 Feb; 62():469-78. PubMed ID: 24184921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.